![]() |
市場調査レポート
商品コード
1618281
ダーマフィラー市場の評価:製品タイプ・用途・成分・エンドユーザー・地域別の機会および予測 (2018-2032年)Dermal Fillers Market Assessment, By Product Type, By Application, By Ingredients, By End-user, By Region, Opportunities and Forecast, 2018-2032F |
||||||
カスタマイズ可能
|
ダーマフィラー市場の評価:製品タイプ・用途・成分・エンドユーザー・地域別の機会および予測 (2018-2032年) |
出版日: 2024年12月20日
発行: Market Xcel - Markets and Data
ページ情報: 英文 241 Pages
納期: 3~5営業日
|
世界のダーマフィラーの市場規模は、2024年の65億7,000万米ドルから、予測期間中は9.30%のCAGRで推移し、2032年には132億9,000万米ドルの規模に成長すると予測されています。
ダーマフィラーは美容皮膚科で使用される注入剤であり、特定の皮膚領域の容積を増加させ、しわ、小じわ、たるみの見た目を減少させるように設計されています。一般的にコラーゲン、ヒアルロン酸、または合成物質で構成されるダーマフィラーの目的は、皮膚の増強による若々しい見た目の回復です。この非侵襲的な美容プロセスは、老化の兆候に対処する有効性から人気が高まっています。これらは外科手術に伴う回復時間を必要とすることなく、人々に生き生きとした容姿を与える一時的なオプションです。
いくつかの要因が世界のダーマフィラー市場に大きな影響を与えています。ダーマフィラーの需要は、顧客の美意識の高まりと痛みの少ない処置への嗜好により増加しています。さらに、自然に見える結果を確実にし、より長く持続させる製品処方の進歩が業界の成長を助けています。市場を促進するもう一つの要因は世界の高齢化であり、特に先進国ではアンチエイジング製品を求める人が増えているため、市場が拡大しています。ダーマフィラー市場を安定的に上昇させる重要な促進要因は、世界の美を向上させる施術へのアクセスの増加と、そのような施術の受け入れの拡大です。
当レポートでは、世界のダーマフィラーの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。
Global dermal fillers market is projected to witness a CAGR of 9.30% during the forecast period 2025-2032, growing from USD 6.57 billion in 2024 to USD 13.29 billion in 2032. Dermal fillers are injectable substances used in cosmetic dermatology designed to increase the volume of certain skin areas to reduce the appearance of wrinkles, fine lines, and sagging. The goal of dermal fillers, typically composed of collagen, hyaluronic acid, or synthetic substances, is to restore a young appearance of skin augmentation. This non-invasive cosmetic process has grown in popularity because of its effectiveness in addressing indications of aging. It provides people with a temporary option to get a revitalized appearance without requiring the recovery time that is usually connected with surgical procedures.
Several factors significantly influence the global dermal filler market. Demand for dermal fillers has increased due to customers' growing aesthetic consciousness and preference for less painful procedures. Additionally, advancements in product formulas that ensure results that seem natural and last longer help the industry grow. Another driver propelling the market is the globally aging population, which is expanding the market, especially in developed nations, as people seek out anti-aging products more and more. Significant drivers driving the dermal fillers market towards a steady rise are the growing accessibility of beauty-enhancing procedures worldwide and the growing acceptance of such procedures. For example, CollPlant Biotechnologies Ltd. reported in November 2023 that the United States Patent and Trademark Office had granted a patent to its photocurable dermal filler product. The product has the ability to regenerate tissue and raise the skin.
Rising Consumer Awareness Boosts Market Growth
Consumers' growing awareness of aesthetics is one of the main reasons propelling the global dermal fillers market. This phenomenon is intimately related to the increasing emphasis on individual well-being and the progressive development of societal standards. People are gaining the ability to choose objects that align with their aesthetic preferences as societies embrace a more expansive definition of beauty. Because people want to alter their physical appearance to meet their notions of beauty, the demand for cosmetic procedures, such as dermal fillers, has significantly increased. The catalyst for aesthetic sensibility is the result of many factors coming together. In the modern era, social media platforms and digital communication have completely changed how people view and portray themselves. Social media's pervasive influence raises people's awareness of aesthetic potential by exposing them to beauty standards and ideals. Driven by the desire to achieve a younger and more refreshed look, people research cosmetic procedures like dermal injections to achieve or surpass their expectations. Furthermore, prominent figures and celebrities' normalization of these treatments fosters a broader public acceptance of the pursuit of aesthetic modifications. Innovative product launches in the market further enhance market growth while boosting awareness.
For example, in March 2023, Israeli beauty company Hallura Ltd. reported successful outcomes from a multi-site European clinical trial for their next-generation hyaluronic acid dermal filler, the BiOLinkMatrix platform. The safety and efficacy of the filler have been assessed in several applications, including nasolabial fold repair, lip and cheek enhancement, and more.
Technological Developments to Fuel Market Growth
Treatment options have been transformed by advancements in filler compositions, including the introduction of hyaluronic acid-based fillers with different levels of cross-linking. Because of these developments, professionals can now tailor their therapies to produce better, more durable results. For example, new biodegradable and bioresorbable fillers address sustainability issues and appeal more to consumers who care about the environment. Furthermore, sophisticated injection techniques have increased the accuracy and efficacy of dermal filler administration, reducing patient discomfort and recovery time. As more people look for non-surgical choices for aesthetic enhancements, demand has been further stimulated by the growth in minimally invasive procedures. Furthermore, as research and development continue, projects are broadening the range of dermal filler treatments beyond conventional ones like wrinkle treatment and lip augmentation to include volume restoration and facial contouring. This continuous innovation drives market growth and enhances consumer confidence in aesthetic procedures, solidifying the role of technology as a key factor in the dermal fillers market expansion. One of the most notable advancements is the introduction of microdroplet injection techniques used with products like Juvederm Skinvive, launched in May 2024. This method allows for more precise and natural-looking enhancements by delivering smaller amounts of filler in multiple microdroplets, resulting in smoother and more subtle results that integrate seamlessly with the skin.
Biodegradable Fillers Segment Dominates the Dermal Fillers Market
Biodegradable fillers are emerging as a significant driver of the global dermal fillers market, reflecting a growing consumer preference for sustainable and safe aesthetic solutions. These fillers, made from naturally occurring substances like hyaluronic acid and poly-L-lactic acid, offer several advantages that align with current market trends. The biodegradable segment is particularly appealing due to its eco-friendly nature, as these fillers can be safely absorbed by the body over time, reducing the risk of long-term complications associated with non-biodegradable options. The increasing acceptance of minimally invasive procedures has fueled the demand for biodegradable fillers. Patients appreciate their temporary results, which allow for adjustments in treatment as preferences evolve.
As consumers become more environmentally conscious, the shift towards biodegradable options will continue, positioning these fillers as a key growth area in the aesthetic medicine sector. This trend not only reflects changing consumer attitudes but also presents lucrative opportunities for companies involved in developing and distributing innovative biodegradable dermal fillers. For instance, AbbVie Inc. introduced HArmonyCa, an injectable, biodegradable dermal filler with lidocaine that uses hyaluronic acid for instant lift and calcium hydroxylapatite (CaHA) for long-term collagen stimulation, in April 2023.
North America Dominates Dermal Fillers Market Share
North America is poised to have the highest market share in the global dermal fillers market. The region's strong position can be attributed to various factors that work together to give it dominance in the market. The area has a developed and well-established healthcare system, particularly in the areas of aesthetic and cosmetic medicine. A number of variables, such as social emphasis on youth and changes in beauty standards, contribute to the high rate of people receiving cosmetic operations in countries like the United States and Canada. Additionally, the population of North America has more disposable income, enabling more people to both afford and select dermal filler procedures. Galderma Laboratories, L.P.'s tailored treatment, RESTYLANE EYELIGHT, debuted in Canada in May 2023. Enhancing infraorbital hollowing is its goal. The injectable dermal filler RESTYLANE EYELIGHT, which contains hyaluronic acid, is designed to fill up the spaces under the eyes, eliminating bags and reducing the look of age and/or exhaustion. It contains hyaluronic acid as a component of their NASHA gel technology.
Future Market Scenario (2025-2032F)
The dermal filler market is set to grow because of new developments in technology, life sciences, and materials research. There is a rising need for non-invasive treatments that will boost innovation. New technologies like AI-powered devices, super-resolution imaging, and government funding for R&D will help the market grow even more in the next few years.
Furthermore, technological advancements like AI integration in laser devices are changing the field by improving image analysis and making research processes faster, which greatly supports market growth. Other than this, innovations are the supporting pillars of this ever-growing market. For instance, Croma-Pharma GmbH introduced PhilArt, a whole range of injectable skin enhancers, in April 2023. PhilArt is an injectable gel made of long-chain polynucleotides that rejuvenates the skin, restores its suppleness, scavenges free radicals, hydrates the skin, fosters the creation of fibroblasts and fibers, and encourages the body's cell regeneration.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.